Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Insmed Inc (INSM)  
$24.77 0.33 (1.31%) as of 4:30 Fri 5/17


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 151,572,000
Market Cap: 3.75(B)
Last Volume: 501,923 Avg Vol: 500,542
52 Week Range: $18.69 - $31.74
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Insmed is a biopharmaceutical company. Co.'s commercial product, ARIKAYCE, is approved in the U.S. for the treatment of Mycobacterium avium complex lung disease and in Europe for the treatment of nontuberculous mycobacterial lung infections. Co.'s pipelines include: brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis, cystic fibrosis and other neutrophil-mediated diseases; and treprostinil palmitil inhalation powder, an inhaled formulation of the treprostinil prodrug treprostinil palmitil for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 95,000
Total Buy Value $0 $0 $0 $1,709,450
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 5
Total Shares Sold 68,472 237,584 371,539 770,027
Total Sell Value $1,743,698 $6,773,897 $9,893,464 $19,734,944
Total People Sold 7 7 7 7
Total Sell Transactions 7 28 33 65
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 412
  Page 1 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Adsett Roger Chief Operating Officer   •       –      –    2024-05-17 4 AS $25.09 $149,160 D/D (5,945) 149,275     -
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2024-05-17 4 AS $25.09 $116,468 D/D (4,642) 106,134     -
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2024-05-14 4 S $25.47 $271,001 D/D (10,640) 110,776 1%     
   Schaeffer Orlov S Nicole Chief People Strategy Officer   •       –      –    2024-05-14 4 S $25.53 $166,149 D/D (6,508) 108,760 1%     
   Adsett Roger Chief Operating Officer   •       –      –    2024-05-14 4 S $25.50 $200,354 D/D (7,857) 155,220 1%     
   Smith Michael Alexander Chief Legal Officer   •       –      –    2024-05-14 4 S $25.40 $129,362 D/D (5,093) 94,579 1%     
   Wise John Drayton Chief Commercial Officer   •       –      –    2024-05-14 4 S $25.47 $129,591 D/D (5,088) 123,259 1%     
   Lewis William Chair and CEO   •       •      –    2024-05-14 4 S $25.52 $566,493 D/D (22,198) 384,125 1%     
   Bonstein Sara Chief Financial Officer   •       –      –    2024-05-14 4 S $25.32 $280,748 D/D (11,088) 117,481 1%     
   Sharoky Melvin Md Director   –       •      –    2024-05-13 4 A $0.00 $0 D/D 13,162 308,177     -
   Lee Leo Director   –       •      –    2024-05-13 4 A $0.00 $0 D/D 13,162 124,619     -
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2024-05-13 4 A $0.00 $0 D/D 14,518 121,416     -
   Schafer Carol Director   –       •      –    2024-05-13 4 A $0.00 $0 D/D 13,162 58,259     -
   Mcgirr David W J Director   –       •      –    2024-05-13 4 A $0.00 $0 D/D 13,162 98,915     -
   Schaeffer Orlov S Nicole Chief People Strategy Officer   •       –      –    2024-05-13 4 A $0.00 $0 D/D 13,308 115,268     -
   Adsett Roger Chief Operating Officer   •       –      –    2024-05-13 4 A $0.00 $0 D/D 14,518 163,077     -
   Smith Michael Alexander Chief Legal Officer   •       –      –    2024-05-13 4 A $0.00 $0 D/D 13,308 99,672     -
   Wise John Drayton Chief Commercial Officer   •       –      –    2024-05-13 4 A $0.00 $0 D/D 14,518 128,347     -
   Lewis William Chair and CEO   •       •      –    2024-05-13 4 A $0.00 $0 D/D 42,707 406,323     -
   Desjardins Clarissa Director   –       •      –    2024-05-13 4 A $0.00 $0 D/D 13,162 61,949     -
   Altomari Alfred Director   –       •      –    2024-05-13 4 A $0.00 $0 D/D 13,162 69,495     -
   Anderson Elizabeth M Director   –       •      –    2024-05-13 4 A $0.00 $0 D/D 13,162 68,671     -
   Bonstein Sara Chief Financial Officer   •       –      –    2024-05-13 4 A $0.00 $0 D/D 14,518 128,569     -
   Brennan David R Director   –       •      –    2024-05-13 4 A $0.00 $0 D/D 13,162 121,875     -
   Sharoky Melvin Md Director   –       •      –    2024-02-28 4 GA $0.00 $0 I/I 3,600 4,699     -
  412 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us